Pharmaceuticals occupiers in Raleigh-Durham typically cluster in Downtown Durham, plan ~220 sqft per seat at high-end fit-out ($155–220/sqft), and pay around 36 USD/sqft ($36 USD) on Class A.
Pharmaceuticals occupiers in Raleigh-Durham typically cluster in Downtown Durham, plan ~220 sqft per seat at high-end fit-out">fit-out ($155–220/sqft), and pay around 36 USD/sqft ($36 USD) on Class A.
Pharmaceuticals occupiers in Raleigh-Durham typically anchor in Downtown Durham. Tech, biotech, university spinouts, creative agencies.
Class A rent in Raleigh-Durham runs 36 USD/sqft ($36 USD) on a 10-year lease with 12 months free. Prime submarkets sit at or modestly above the city index.
Typical pharmaceuticals fit-out targets high-end specification at $155–220/sqft. Branded reception, full client-facing programming, premium furniture, and specialist AV are standard.
Plan around 220 sqft per seat blended (workstation + circulation + amenity). A 100-headcount pharma office in Raleigh-Durham typically targets 22,000 sqft of leasable area.
Commercial and medical-affairs teams cluster near academic-medical anchors; large floor plates support cross-functional brand teams. Among the deepest tech and life-sciences talent pools in the US Southeast — anchored by Duke, UNC Chapel Hill, and NC State. Strong in-migration from the Northeast and West Coast continues to broaden the engineering and biotech base.
Headline corporate tax: 23%. Modified-gross structures. 10-year terms standard. Free rent of 10-14 months and TI of $80-$120/sqft typical on a 10-year Class A deal.
| city | Raleigh-Durham |
|---|---|
| industry | Pharmaceuticals |
| naics | 3254, 5417 |
| preferredSubmarket | Downtown Durham |
| preferredFitoutSpec | High-end |
| fitoutBand | $155–220/sqft |
| sqftPerSeat | 220 |
| classARentLocal | 36 USD/sqft/yr |
| classARentUsd | $36/sqft/yr |
| vacancyPct | 16.8% |
| typicalLeaseYears | 10 |
| typicalRentFreeMonths | 12 |
| talentIndex | 80 |
| corporateTaxPct | 23% |
Reviewed by Class A Atlas Editorial Desk — House byline · global editorial team. Last updated 2026-04-15. See our methodology and editorial standards.